医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

广告
第一作者: Sathyen A,Prabhu
第一单位: Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.;Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
作者单位: Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.;Division of Experimental Medicine, McGill University, Montréal, Québec, Canada. [1] Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada. [2] Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada. [3] Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.;Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada. [4] Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [5] Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. [6] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [7] Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.;Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.;Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada. [8] Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. [9] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.;University of Toronto, Toronto, Ontario, Canada. [10] Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.;Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.;Department of Medicine, Université de Montréal, Montréal, Québec, Canada. [11] Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.;McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada. [12] Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.;Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.;McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada. [13] Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.;Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.;McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada. [14]
DOI 10.1158/1535-7163.MCT-22-0092
PMID 36722142
发布时间 2023-03-03
提交
  • 浏览2
Molecular cancer therapeutics

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷